| Trial ID: | L6899 |
| Source ID: | NCT04597697
|
| Associated Drug: |
Insulin Icodec
|
| Title: |
A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People With Liver Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Insulin icodec
|
| Outcome Measures: |
Primary: AUC,Ico,0-inf,SD, Area under the serum insulin icodec concentration-time curve after a single dose, From 0 hours until infinity after trial product administration (pmol\*h/L), Day 1 | Secondary: Cmax,Ico,SD, Maximum observed serum insulin icodec concentration after a single dose, From 0 hours until last measurement time after trial product administration (pmol/L), Day 1|tmax,Ico,SD, Time to maximum observed serum insulin icodec concentration after a single dose, From 0 hours until last measurement time after trial product administration (hours), Day 1
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
25
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2020-12-22
|
| Completion Date: |
2022-03-24
|
| Results First Posted: |
|
| Last Update Posted: |
2024-07-12
|
| Locations: |
Pharmaceutical Research Associates CZ, s.r.o., Praha 7, 17000, Czechia|Summit Clinical Research s.r.o., Bratislava, 83101, Slovakia
|
| URL: |
https://clinicaltrials.gov/show/NCT04597697
|
